Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5281912
Max Phase: Preclinical
Molecular Formula: C44H69N15O9S2
Molecular Weight: 1016.27
Associated Items:
ID: ALA5281912
Max Phase: Preclinical
Molecular Formula: C44H69N15O9S2
Molecular Weight: 1016.27
Associated Items:
Canonical SMILES: N=C(N)NCCC[C@@H](NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)c1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC1CCCCC1)C(=O)N[C@H]1CSSC[C@@H](C(N)=O)NC1=O
Standard InChI: InChI=1S/C44H69N15O9S2/c45-34(60)18-17-29(38(64)56-30(22-25-10-3-1-4-11-25)39(65)58-32-24-70-69-23-31(35(46)61)57-40(32)66)54-36(62)27(14-7-19-51-43(47)48)53-37(63)28(15-8-20-52-44(49)50)55-41(67)33-16-9-21-59(33)42(68)26-12-5-2-6-13-26/h2,5-6,12-13,25,27-33H,1,3-4,7-11,14-24H2,(H2,45,60)(H2,46,61)(H,53,63)(H,54,62)(H,55,67)(H,56,64)(H,57,66)(H,58,65)(H4,47,48,51)(H4,49,50,52)/t27-,28-,29+,30+,31+,32+,33+/m1/s1
Standard InChI Key: BBRIVIRAAPNZBF-JREFTJHFSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1016.27 | Molecular Weight (Monoisotopic): 1015.4844 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Brust A, Croker DE, Colless B, Ragnarsson L, Andersson Å, Jain K, Garcia-Caraballo S, Castro J, Brierley SM, Alewood PF, Lewis RJ.. (2016) Conopeptide-Derived κ-Opioid Agonists (Conorphins): Potent, Selective, and Metabolic Stable Dynorphin A Mimetics with Antinociceptive Properties., 59 (6): [PMID:26859603] [10.1021/acs.jmedchem.5b00911] |
Source(1):